Scientists at Public Health England say the first real-world data shows the Pfizer-BioNTech and AstraZeneca-Oxford are nearly as effective against the emerging Indian strain of COVID-19 as they were against the so-called UK 'Kent' variant. Germany says it will donate 100 million euros ($121.83 million) to COVAX along with 30 million surplus doses with J&J also committing 200 million doses to the global facility.

Latest Video
New Stories
-
This exchange on the HTA Review was about as underwhelming as it sounds
October 9, 2025 - - Latest News -
AusBiotech unveils international conference program for Australia’s biggest week in biotech
October 9, 2025 - - Australian Biotech -
Life sciences industry calls for stronger national strategy to support trials and innovation
October 9, 2025 - - Latest News -
Officials outline ongoing measures to address ADHD medicine shortages
October 9, 2025 - - Latest News -
Pharmaceutical spending to rise by around $10 billion, but still lose ground to other programs
October 9, 2025 - - Latest News -
Australian company reports positive outcome from collaboration
October 8, 2025 - - Australian Biotech -
CUREator opens $33 million funding round with CSL and AbbVie partnership
October 8, 2025 - - Latest News